Aimia Past Earnings Performance
Past criteria checks 0/6
Aimia has been growing earnings at an average annual rate of 11.3%, while the Chemicals industry saw earnings growing at 17.5% annually. Revenues have been growing at an average rate of 38.2% per year.
Key information
11.3%
Earnings growth rate
10.6%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 38.2% |
| Return on equity | -18.0% |
| Net Margin | -29.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Aimia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 396 | -117 | 127 | 0 |
| 31 Mar 24 | 313 | -185 | 115 | 0 |
| 31 Dec 23 | 208 | -201 | 90 | 0 |
| 30 Sep 23 | 134 | -158 | 52 | 0 |
| 30 Jun 23 | 578 | 387 | 33 | 0 |
| 31 Mar 23 | 505 | 426 | 21 | 0 |
| 31 Dec 22 | 477 | 428 | 15 | 0 |
| 30 Sep 22 | 482 | 436 | 11 | 0 |
| 30 Jun 22 | -45 | -78 | 12 | 0 |
| 31 Mar 22 | -3 | -40 | 8 | 0 |
| 31 Dec 21 | 13 | -30 | 8 | 0 |
| 30 Sep 21 | 29 | -12 | 6 | 0 |
| 30 Jun 21 | 21 | -26 | 6 | 0 |
| 31 Mar 21 | 20 | -23 | 6 | 0 |
| 31 Dec 20 | 14 | -28 | 10 | 0 |
| 30 Sep 20 | 23 | -1 | 20 | 0 |
| 30 Jun 20 | 54 | 26 | 26 | 0 |
| 31 Mar 20 | 92 | 54 | 29 | 0 |
| 31 Dec 19 | 127 | 69 | 28 | 0 |
| 30 Sep 19 | 145 | -107 | -34 | 0 |
| 30 Jun 19 | 158 | -121 | 8 | 0 |
| 31 Mar 19 | 153 | -167 | 60 | 0 |
| 31 Dec 18 | 167 | -179 | 107 | 0 |
| 30 Sep 18 | -752 | -149 | 79 | 0 |
| 30 Jun 18 | -444 | -194 | 136 | 0 |
| 31 Mar 18 | -125 | -212 | 214 | 0 |
| 31 Dec 17 | 232 | -200 | 299 | 0 |
| 30 Sep 17 | 1,274 | -197 | 480 | 0 |
| 30 Jun 17 | 1,428 | -156 | 529 | 0 |
| 31 Mar 17 | 1,592 | -120 | 556 | 0 |
| 31 Dec 16 | 1,759 | -137 | 581 | 0 |
| 30 Sep 16 | 2,333 | -52 | 670 | 0 |
| 30 Jun 16 | 2,359 | -77 | 680 | 0 |
| 31 Mar 16 | 2,371 | -53 | 636 | 0 |
| 31 Dec 15 | 2,461 | -18 | 630 | 0 |
| 30 Sep 15 | 2,487 | 28 | 619 | 0 |
| 30 Jun 15 | 2,502 | 30 | 614 | 0 |
| 31 Mar 15 | 2,520 | -22 | 664 | 0 |
| 31 Dec 14 | 2,469 | -60 | 677 | 0 |
| 30 Sep 14 | 2,395 | -204 | 880 | 0 |
| 30 Jun 14 | 2,352 | -175 | 825 | 0 |
| 31 Mar 14 | 1,673 | -569 | 854 | 0 |
| 31 Dec 13 | 1,674 | -509 | 839 | 0 |
| 30 Sep 13 | 1,664 | -327 | 609 | 0 |
Quality Earnings: GA7 is currently unprofitable.
Growing Profit Margin: GA7 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GA7 is unprofitable, but has reduced losses over the past 5 years at a rate of 11.3% per year.
Accelerating Growth: Unable to compare GA7's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GA7 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (5%).
Return on Equity
High ROE: GA7 has a negative Return on Equity (-17.96%), as it is currently unprofitable.